These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 16086620

  • 41. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.
    Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS.
    J Clin Psychiatry; 2008 Apr; 69(4):659-65. PubMed ID: 18363420
    [Abstract] [Full Text] [Related]

  • 42. Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study.
    Zajecka JM, Fava M, Shelton RC, Barrentine LW, Young P, Papakostas GI.
    J Clin Psychiatry; 2016 May; 77(5):654-60. PubMed ID: 27035404
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
    Ball SG, Ferguson MB, Martinez JM, Pangallo BA, Nery ES, Dellva MA, Sparks J, Zhang Q, Liu P, Bangs M, Goldberger C.
    J Clin Psychiatry; 2016 May; 77(5):635-42. PubMed ID: 27035159
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.
    Hirose S, Ashby CR.
    J Clin Psychiatry; 2002 Aug; 63(8):733-6. PubMed ID: 12197455
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.
    Sáiz-Ruiz J, Ibáñez A, Díaz-Marsá M, Arias F, Padín J, Martín-Carrasco M, Montes JM, Ferrando L, Carrasco JL, Martín-Ballesteros E, Jordá L, Chamorro L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1129-34. PubMed ID: 12452535
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC.
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
    McIntyre A, Gendron A, McIntyre A.
    Depress Anxiety; 2007 Apr; 24(7):487-94. PubMed ID: 17177199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.